Inactive Instrument

PDL BioPharma, Inc.

PDLI

US69329Y1047

Biotechnology & Medical Research

PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell Microcap Value Index

December 30, 2020 at 12:00 am EST

Latest news about PDL BioPharma, Inc.

PDL BioPharma, Inc.'s Equity Buyback announced on December 9, 2019 has expired with the repurchase of 15,532,000 shares, representing 12.91% for $50.39 million.	21-12-30	CI
Tranche Update on PDL BioPharma, Inc.'s Equity Buyback Plan announced on December 9, 2019.	21-03-29	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from S&P Global BMI Index	21-01-05	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from S&P TMI Index	21-01-05	CI
PDL BioPharma, Inc.(NasdaqGM:PDLI) dropped from NASDAQ Biotechnology Index	21-01-01	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2000 Dynamic Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2000 Value-Defensive Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2000 Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 3000 Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2500 Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2000 Value Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell Small Cap Completeness Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell Small Cap Comp Value Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2500 Value Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 3000 Value Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell Microcap Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 3000E Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 3000E Value Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell Microcap Value Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2000 Defensive Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2500 Defensive Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2500 Dynamic Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2000 Value-Dynamic Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2500 Value-Defensive Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2500 Value-Dynamic Index	20-12-30	CI

PDL BioPharma, Inc. has a portfolio of income generating assets based on alternative financings. These alternative financings fall into one of three categories: royalty monetization, debt structures and hybrids of the two. The Company's investments are typically in assets with strong intellectual property protection and are commercial stage or soon-to-be approved. The counterparties in these transactions can be biotechs, pharmas, medtech companies, universities and inventors.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research